Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses.

Orsini JA, Snooks-Parsons C, Stine L, Haddock M, Ramberg CF, Benson CE, Nunamaker DM.

Can J Vet Res. 2005 Oct;69(4):278-86.

2.

Aminoglycoside resistant enterococcal endocarditis.

Eliopoulos GM.

Infect Dis Clin North Am. 1993 Mar;7(1):117-33. Review.

PMID:
8463648
3.
4.
5.

Issues regarding the use of vancomycin in companion animals.

Weese JS.

J Am Vet Med Assoc. 2008 Aug 15;233(4):565-7. doi: 10.2460/javma.233.4.565. No abstract available.

PMID:
18710310
7.
8.

Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.

Fogel MA, Nussbaum PB, Feintzeig ID, Hunt WA, Gavin JP, Kim RC.

Am J Kidney Dis. 1998 Sep;32(3):401-9.

PMID:
9740155
9.

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG.

Clin Infect Dis. 1995 May;20(5):1137-44.

PMID:
7619989
10.

Enterococcal resistance--an overview.

Marothi YA, Agnihotri H, Dubey D.

Indian J Med Microbiol. 2005 Oct;23(4):214-9. Review.

11.
12.

Telavancin: a novel lipoglycopeptide for serious gram-positive infections.

Laohavaleeson S, Kuti JL, Nicolau DP.

Expert Opin Investig Drugs. 2007 Mar;16(3):347-57. Review.

PMID:
17302529
13.
14.

Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.

Sgarabotto D, Cusinato R, Narne E, Scano F, Zignol M, Gambino A, Cattelan A, Meneghetti F, Cadrobbi P.

Scand J Infect Dis. 2002;34(2):122-6.

PMID:
11928842
15.

[Gram-positive bacterial infections resistant to antibiotic treatment].

Utili R.

Ann Ital Med Int. 2001 Oct-Dec;16(4):205-19. Review. Italian.

PMID:
11799629
16.

The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.

Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD.

Am J Infect Control. 1995 Jun;23(3):170-80.

PMID:
7677262
17.

Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.

Chua K, Howden BP.

Curr Opin Infect Dis. 2009 Dec;22(6):525-34. doi: 10.1097/QCO.0b013e328331fbcd. Review.

PMID:
19738465
18.
19.

Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.

Hegde SS, Reyes N, Wiens T, Vanasse N, Skinner R, McCullough J, Kaniga K, Pace J, Thomas R, Shaw JP, Obedencio G, Judice JK.

Antimicrob Agents Chemother. 2004 Aug;48(8):3043-50.

20.

Optimizing therapy for vancomycin-resistant enterococci (VRE).

Linden PK.

Semin Respir Crit Care Med. 2007 Dec;28(6):632-45. Review.

PMID:
18095227

Supplemental Content

Support Center